Literature DB >> 8039117

Establishment and characterization of four human epithelial ovarian carcinoma cell lines.

H W Hirte1, J S Kaiser, S Bacchetti.   

Abstract

BACKGROUND: To develop in vitro models of human ovarian carcinoma, fresh tumour cells derived from malignant effusions were cultured in vitro in the presence or absence of serum to establish cell lines.
METHODS: Cell lines established were characterized by morphology in culture, surface marker expression, cytogenetic analysis, and growth in anchorage-dependent and anchorage-independent conditions.
RESULTS: Four cell lines (MAC-2, RIC-2, SCHM-1, and SIB-1) were established from tumor cells isolated from the malignant effusions of four patients with epithelial ovarian carcinoma. These lines were able to grow in the presence of low concentrations of serum (3%), and two lines grew in the absence of serum (MAC-2 and SIB-1). All cell lines have been grown continuously for longer than 6 months. One cell line (SCHM-1) grew only in liquid medium whereas the other lines grew in both liquid and semi-solid media. Chromosome analysis revealed aneuploidy in three of the four lines. All of the lines stained positively for CA-125 and HMFG-2, consistent with an epithelial origin.
CONCLUSION: The ability of these cells to grow in low concentrations of serum or in serum-free conditions should prove useful for the in vitro study of factors affecting the growth of human ovarian carcinoma. The serum-free medium developed will be of use in the isolation of factors from the conditioned medium of these cell lines and previously established cell lines.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8039117     DOI: 10.1002/1097-0142(19940801)74:3<900::aid-cncr2820740317>3.0.co;2-n

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Characterization of four novel epithelial ovarian cancer cell lines.

Authors:  D M Provencher; H Lounis; L Champoux; M Tétrault; E N Manderson; J C Wang; P Eydoux; R Savoie; P N Tonin; A M Mes-Masson
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-06       Impact factor: 2.416

2.  Establishment of a New Ovarian Cancer Cell Line CA5171.

Authors:  Ying-Cheng Chiang; Wen-Fang Cheng; Ming-Cheng Chang; Tzu-Pin Lu; Kuan-Ting Kuo; Hsiu-Ping Lin; Chang-Yao Hsieh; Chi-An Chen
Journal:  Reprod Sci       Date:  2014-11-12       Impact factor: 3.060

3.  Inhibition of calcium-independent phospholipase A2 suppresses proliferation and tumorigenicity of ovarian carcinoma cells.

Authors:  Yuanda Song; Palmer Wilkins; Wenhui Hu; Karnam S Murthy; Jing Chen; Zendra Lee; Regina Oyesanya; Jinhua Wu; Suzanne E Barbour; Xianjun Fang
Journal:  Biochem J       Date:  2007-09-15       Impact factor: 3.857

4.  Establishment and characterization of a cell line (NOMH-1) originating from a human endometrioid adenocarcinoma of the ovary.

Authors:  Takashi Yamada; Takayoshi Kanda; Hiroshi Mori; Kaname Shimokawa; Mitsuo Kagawa; Yuro Shibayama
Journal:  J Ovarian Res       Date:  2013-02-04       Impact factor: 4.234

5.  Characterization of three new serous epithelial ovarian cancer cell lines.

Authors:  Véronique Ouellet; Magdalena Zietarska; Lise Portelance; Julie Lafontaine; Jason Madore; Marie-Line Puiffe; Suzanna L Arcand; Zhen Shen; Josée Hébert; Patricia N Tonin; Diane M Provencher; Anne-Marie Mes-Masson
Journal:  BMC Cancer       Date:  2008-05-28       Impact factor: 4.430

6.  Temperature-sensitive ovarian carcinoma cell line (OvBH-1).

Authors:  Julia K Bar; Antonina Harlozinska; Sabine Kartarius; Mathias Montenarh; Ewa Wyrodek; Jan M Rodriguez Parkitna; Marian Kochman; Andrzej Ozyhar
Journal:  Jpn J Cancer Res       Date:  2002-09

7.  Characterization of Mutational Status, Spheroid Formation, and Drug Response of a New Genomically-Stable Human Ovarian Clear Cell Carcinoma Cell Line, 105C.

Authors:  Bart Kolendowski; Yudith Ramos Valdes; Hal Hirte; Hiroaki Itamochi; Wonjae Lee; Mark Carey; Trevor G Shepherd; Gabriel E DiMattia
Journal:  Cells       Date:  2020-11-03       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.